The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2022 | Survival gap between adult and pediatric cases of Hodgkin lymphoma
Kara Kelly, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, speaks on the survival gap between adult and pediatric cases of Hodgkin lymphoma which is driven by a host of factors, including differences in gene expression, as well as social determinants of health. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.
